Effect of fingolimod on diffuse brain tissue damage in relapsing-remitting multiple sclerosis patients

The effect of fingolimod on diffuse damage is partly independent of its treatment effect on focal damage, suggesting that both inflammatory and neurodegenerative components of MS are affected.